Clinical Trial Update: Safety of Somatropin and Induction of Puberty With 17-beta-oestradiol in Girls With Turner Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the safety of somatropin therapy and puberty induction with 17-beta-estradiol in girls with Turner syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Turner Syndrome

Drugs mentioned

• 17-Beta Estradiol (17-beta estradiol)
• Somatropin (somatropin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Genetic Disorder, Turner Syndrome | Phase 4 | Status: COMPLETED